Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Otilimab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
    MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results

    03 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220803005637/en

    BUSINESSWIRE
    03 Aug 2022
    Share Share
    GSK side-lines COVID drug otilimab to focus on Xevudy
    GSK side-lines COVID drug otilimab to focus on Xevudy

    28 Oct 2021

    // Phil Taylor PHARMAPHORUM

    https://pharmaphorum.com/news/gsk-side-lines-covid-drug-otilimab-to-focus-on-xevudy/

    Phil Taylor PHARMAPHORUM
    28 Oct 2021
    Share Share
    GSK to amend Covid-19 study to confirm efficacy in older patients
    GSK to amend Covid-19 study to confirm efficacy in older patients

    25 Feb 2021

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/gsk-amend-covid-19-antibody-study/

    CLINICALTRIALSARENA
    25 Feb 2021
    Share Share
    Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy
    Anti-inflammatory and cancer drugs tested in UK as possible COVID-19 therapy

    11 Jun 2020

    // Paul Sandle ECONOMICTIMES

    https://health.economictimes.indiatimes.com/news/pharma/anti-inflammatory-and-cancer-drugs-tested-in-uk-as-possible-covid-19-therapy/76303703

    Paul Sandle ECONOMICTIMES
    11 Jun 2020
    Share Share
    Hydroxychloroquine fails to show benefit in Covid-19 study
    Hydroxychloroquine fails to show benefit in Covid-19 study

    08 May 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/hydroxychloroquine-study-covid-19-data/

    CLINICALTRIALSARENA
    08 May 2020
    Share Share
    GSK to test experimental drug to treat pneumonia from COVID-19
    GSK to test experimental drug to treat pneumonia from COVID-19

    07 May 2020

    // REUTERS

    https://www.reuters.com/article/us-health-coronavirus-gsk-otilimab/gsk-to-test-experimental-drug-to-treat-pneumonia-from-covid-19-idUSKBN22J22L

    REUTERS
    07 May 2020
    Share Share